RUCH JOSHUA — SEC Form 4 filings
SEC reporting owner CIK 943431. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-24 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 1 filing — 38,000 shares, $6,093,967 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 11,234 shares @ $161.16 ($1,810,437) in GeneDx Holdings Corp., filed 2025-11-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | Director | 9 | — | 15 legs · 38,000 sh · $6,093,967 | 15 |
Form 4 filings — RUCH JOSHUA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,576 @ $0 · Grant/award (A): 4,248 (derivative) @ $0 · Option exercise (M): 3,576 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 201 @ $158.40 · Sale (S): 625 @ $159.28 · Sale (S): 889 @ $160.45 · Sale (S): 1,117 @ $161.16 · Sale (S): 72 @ $162.04 · Sale (S): 407 @ $158.40 · +9 more | EDGAR |
| 2025-06-23 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 12,924 @ $0 · Grant/award (A): 3,576 (derivative) @ $0 · Option exercise (M): 12,924 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 5,816 @ $7.89 · Option exercise (M): 5,816 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,000 @ $7.89 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4/A | GeneDx Holdings Corp. (WGS) | Holdings only — no transactions reported | EDGAR |
| 2024-10-17 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 130 · Option exercise (M): 130 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | GeneDx Holdings Corp. (WGS) | Grant/award (A): 12,924 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 5,828 @ $0 · Option exercise (M): 5,828 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=943431 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →